FAKTOR OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 02:50:38 2024-07-10 am EDT | ||
| 15.04 EUR | +0.20% |
|
| Current month | +0.60% | ||
| 1 month | +5.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-10 | 15.04 | +0.20% |
| 24-07-09 | 15.01 | +2.67% |
| 24-07-08 | 14.62 | +0.34% |
| 24-07-05 | 14.57 | +1.25% |
| 24-07-04 | 14.39 | -0.48% |
Delayed Quote Deutsche Boerse AG
Last update July 10, 2024 at 02:50 am EDT
More quotesStatic data
| Product type | Warrant Esotici e Strutturati |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PH2AMG |
| ISIN | DE000PH2AMG1 |
| Date issued | 2020-02-27 |
| Strike | 311.5 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.17 € |
|---|---|
| Lowest since issue | 6.7 € |
| Spread | 0.06 € |
| Spread % | 0.40% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
315.9
USD
Average target price
316.4
USD
Spread / Average Target
+0.17%
- Stock Market
- Certificates
- Certificat
